Targeted immunotherapy in Hodgkin lymphoma

Blood. 2015 Jun 25;125(26):3967-8. doi: 10.1182/blood-2015-05-641712.

Abstract

In this issue of Blood, Rothe et al introduce a new principle of targeted Hodgkin lymphoma (HL) immunotherapy in their report from a phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13.

Publication types

  • Comment

MeSH terms

  • Antibodies, Bispecific / administration & dosage*
  • Female
  • Hodgkin Disease / drug therapy*
  • Humans
  • Immunotherapy / methods*
  • Male

Substances

  • Antibodies, Bispecific